Risultati della ricerca - Matas-Cespedes, Alba

  • Mostra 1 - 8 risultati su 8
Raffina i risultati
  1. 1
    Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies

    Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies di Bareham, Bethany, Georgakopoulos, Nikitas, Matas-Céspedes, Alba, Curran, Michelle, Saeb-Parsy, Kourosh

    Pubblicazione 2021
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome

    Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome di Matas‐Céspedes, Alba, Brown, Lee, Mahbubani, Krishnaa T, Bareham, Bethany, Higgins, Jackie, Curran, Michelle, de Haan, Lolke, Lapointe, Jean‐Martin, Stebbings, Richard, Saeb‐Parsy, Kourosh

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  3. 3
    The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status

    The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational sta... di Vidal-Crespo, Anna, Rodriguez, Vanina, Matas-Cespedes, Alba, Lee, Eriong, Rivas-Delgado, Alfredo, Giné, Eva, Navarro, Alba, Beà, Sílvia, Campo, Elias, López-Guillermo, Armando, Lopez-Guerra, Monica, Roué, Gaël, Colomer, Dolors, Pérez-Galán, Patricia

    Pubblicazione 2017
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  4. 4
    The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia

    The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia di Matas-Céspedes, Alba, Vidal-Crespo, Anna, Rodriguez, Vanina, Villamor, Neus, Delgado, Julio, Giné, Eva, Roca-Ho, Heleia, Menéndez, Pablo, Campo, Elías, López-Guillermo, Armando, Colomer, Dolors, Roué, Gaël, Wiestner, Adrian, Parren, Paul W.H.I., Doshi, Parul, van Bueren, Jeroen Lammerts, Pérez-Galán, Patricia

    Pubblicazione 2016
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens

    Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens di Vidal-Crespo, Anna, Matas-Céspedes, Alba, Rodriguez, Vanina, Rossi, Cédric, Valero, Juan G., Serrat, Neus, Sanjuan-Pla, Alejandra, Menéndez, Pablo, Roué, Gaël, López-Guillermo, Armando, Giné, Eva, Campo, Elías, Colomer, Dolors, Bezombes, Christine, van Bueren, Jeroen Lammerts, Chiu, Christopher, Doshi, Parul, Pérez-Galán, Patricia

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  6. 6
    3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma

    3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma di Gava, Fabien, Faria, Carla, Gravelle, Pauline, Valero, Juan G., Dobaño-López, Cèlia, Morin, Renaud, Norlund, Marine, Gomes, Aurélie, Lagarde, Jean-Michel, Rossi, Cédric, Bordenave, Julie, Pieruccioni, Laetitia, Rouquette, Jacques, Matas-Céspedes, Alba, Fournié, Jean-Jacques, Ysebaert, Loïc, Laurent, Camille, Pérez-Galán, Patricia, Bezombes, Christine

    Pubblicazione 2021
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  7. 7
    The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

    The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma di Valero, Juan Garcia, Matas-Céspedes, Alba, Arenas, Fabián, Rodriguez, Vanina, Carreras, Joaquim, Serrat, Neus, Guerrero-Hernández, Martina, Yahiaoui, Anella, Balagué, Olga, Martin, Silvia, Capdevila, Cristina, Hernández, Lluis, Magnano, Laura, Rivas-Delgado, Alfredo, Tannheimer, Stacey, Cid, Maria C., Campo, Elías, López-Guillermo, Armando, Colomer, Dolors, Pérez-Galán, Patricia

    Pubblicazione 2021
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:
  8. 8
    PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax

    PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax di Serrat, Neus, Guerrero-Hernández, Martina, Matas-Céspedes, Alba, Yahiaoui, Anella, Valero, Juan G., Nadeu, Ferran, Clot, Guillem, Di Re, Miriam, Corbera-Bellalta, Marc, Magnano, Laura, Rivas-Delgado, Alfredo, Enjuanes, Anna, Beà, Silvia, Cid, Maria C., Campo, Elías, Montero, Joan, Hodson, Daniel J., López-Guillermo, Armando, Colomer, Dolors, Tannheimer, Stacey, Pérez-Galán, Patricia

    Pubblicazione 2020
    Testo Testo Testo
    testo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: